Show simple item record

dc.contributor.authorMead, A
dc.contributor.authorButt, N
dc.contributor.authorNagi, W
dc.contributor.authorWhiteway, A
dc.contributor.authorKirkpatrick, S
dc.contributor.authorRinaldi, C
dc.contributor.authorRoughley, C
dc.contributor.authorAckroyd, S
dc.contributor.authorEwing, J
dc.contributor.authorNeelakantan, P
dc.contributor.authorGarg, M
dc.contributor.authorHarrison, C
dc.contributor.authorTucker, D
dc.contributor.authorCollington, S
dc.contributor.authorChiu, G
dc.contributor.authorHickey, J
dc.contributor.authorSomervaille, Tim CP
dc.date.accessioned2019-06-04T09:44:28Z
dc.date.available2019-06-04T09:44:28Z
dc.date.issued2019en
dc.identifier.citationMead A, Butt N, Nagi W, Whiteway A, Kirkpatrick S, Rinaldi C, et al. A retrospective real world evidence study to review the current treatment pathways for myelofibrosis from across the United Kingdom (The REALISM UK Study). Br J Haematol. 2019; 185:08.en
dc.identifier.urihttp://hdl.handle.net/10541/621836
dc.language.isoenen
dc.titleA retrospective real world evidence study to review the current treatment pathways for myelofibrosis from across the United Kingdom (The REALISM UK Study))en
dc.typeMeetings and Proceedingsen
dc.contributor.departmentOxford University Hospitals NHS Foundation Trust, Oxforden
dc.identifier.journalBritish Journal of Haematologyen


This item appears in the following Collection(s)

Show simple item record